Butanol Extract of Acanthopanax senticosus (Rupr. et Maxim.) Harms Alleviates Atherosclerosis in Apolipoprotein E‐Deficient Mice Fed a High‐Fat Diet. Issue 4 (20th March 2023)

• Record Type: Journal Article
• Authors: Jia, Ailing; Shi, Yuwen; Zhang, Yuhang; Diao, Yuanyuan; Chang, Baijin; Jiang, Mengcheng; Liu, Weipeng; Qiu, Zhidong; Fu, Chaomei; Qiu, Ye
• Is Part Of: Chemistry & biodiversity. Volume 20:Issue 4(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-03-20
• Subjects: Atherosclerosis -- Gut microbiota -- Inflammation -- Lipids -- Butanol extract of Acanthopanax senticosus (Rupr. et Maxim.) Harms; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Biodiversity -- Periodicals; 572
• DOI: 10.1002/cbdv.202200949
• Languages: English
• ISSNs: 1612-1872

Abstract

Abstract: This study investigated the effect of butanol extract of AS (ASBUE) on atherosclerosis in apolipoprotein E‐deficient (ApoE −/−) mice. The mice were administered ASBUE (390 or 130 mg/kg/day) or rosuvastatin (RSV) via oral gavage for eight weeks. In ApoE −/− mice, ASBUE suppressed the abnormal body weight gain and improved serum and liver biochemical indicators. ASBUE remarkably reduced the aortic plaque area, improved liver pathological conditions, and lipid metabolism abnormalities, and altered the intestinal microbiota structure in ApoE −/− mice. In the vascular tissue of ASBUE‐treated mice, P‐IKKβ, P‐NFκB, and P‐IκBα levels tended to decrease, while IκB‐α increased in high fat‐diet‐fed atherosclerotic mice. These findings demonstrated the anti‐atherosclerotic potential of ASBUE, which is mediated by the interaction between the gut microbiota and lipid metabolism and regulated via the Nuclear Factor‐kappa B (NF‐κB) pathway. This work paves the groundwork for subsequent studies to develop innovative drugs to treat atherosclerosis. Abstract :